Skip to main content
SpringerLink
Log in

CRISPR Gene Editing of Hematopoietic Stem and Progenitor Cells

  • Protocol
  • First Online:
Hematopoietic Stem Cells

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2567))

Abstract

Genetic editing of hematopoietic stem and progenitor cells can be employed to understand gene-function relationships underlying hematopoietic cell biology, leading to new therapeutic approaches to treat disease. The ability to collect, purify, and manipulate primary cells outside the body permits testing of many different gene editing approaches. RNA-guided nucleases, such as CRISPR, have revolutionized gene editing based simply on Watson-Crick base-pairing, employed to direct activity to specific genomic loci. Given the ease and affordability of synthetic, custom RNA guides, testing of precision edits or large random pools in high-throughput screening studies is now widely available. With the ever-growing number of CRISPR nucleases being discovered or engineered, researchers now have a plethora of options for directed genomic change, including single base edits, nicks or double-stranded DNA cuts with blunt or staggered ends, as well as the ability to target CRISPR to other cellular oligonucleotides such as RNA or mitochondrial DNA. Except for single base editing strategies, precise rewriting of larger segments of the genetic code requires delivery of an additional component, templated DNA oligonucleotide(s) encoding the desired changes flanked by homologous sequences that permit recombination at or near the site of CRISPR activity. Altogether, the ever-growing CRISPR gene editing toolkit is an invaluable resource. This chapter outlines available technologies and the strategies for applying CRISPR-based editing in hematopoietic stem and progenitor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Broeders M et al (2020) Sharpening the molecular scissors: advances in gene-editing technology. iScience 23:100789

    Article  CAS  PubMed  Google Scholar 

  2. Ishino Y et al (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169:5429–5433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mojica FJ et al (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60:174–182

    Article  CAS  PubMed  Google Scholar 

  4. Anderson WF, Blaese RM, Culver K (1990) The ADA human gene therapy clinical protocol: points to consider response with clinical protocol. Hum Gene Ther 1:331–362

    Article  PubMed  Google Scholar 

  5. Bortesi L et al (2016) Patterns of CRISPR/Cas9 activity in plants, animals and microbes. Plant Biotechnol J 14:2203–2216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Avecilla ST et al (2016) How do I perform hematopoietic progenitor cell selection? Transfusion 56:1008–1012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pickar-Oliver A, Gersbach CA (2019) The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol 20:490–507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Xu S, Luk K, Yao Q et al (2019) Editing aberrant splice sites efficiently restores beta-globin expression in beta-thalassemia. Blood 133:2255–2262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Agudelo D, Duringer A, Bozoyan L et al (2017) Marker-free coselection for CRISPR-driven genome editing in human cells. Nat Methods 14:615–620

    Article  CAS  PubMed  Google Scholar 

  10. Shahbazi R, Sghia-Highes G, Reid JL et al (2019) Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations. Nat Mater 18:1124–1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Thuronyi BW, Koblan LW, Levy JM et al (2019) Continuous evolution of base editors with expanded target compatibility and improved activity. Nat Biotechnol 37:1070–1079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Anzalone AV, Randolph PB, Davis JR et al (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576:149–157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zeng J, Wu Y, Ren C et al (2020) Therapeutic base editing of human hematopoietic stem cells. Nat Med 26:535–541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Newby GA, Yen JS, Woodard KJ et al (2021) Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595:295–302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wu Y, Zeng J, Roscoe BP et al (2019) Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med 25:776–783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Klompe SE, Vo PLC, Halpin-Healy TS et al (2019) Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration. Nature 571:219–225

    Article  CAS  PubMed  Google Scholar 

  17. Hendel A, Bak RO, Clark JT et al (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33:985–989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Osborn MJ, Webber BR, Knipping F et al (2016) Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases. Mol Ther 24:570–581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schumann K, Lin S, Boyer E et al (2015) Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A 112:10437–10442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Gundry MC, Brunetti L, Lin A et al (2016) Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9. Cell Rep 17:1453–1461

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. DeWitt MA, Magis W, Bray NL et al (2016) Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Sci Transl Med 8:360ra134

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lau CH, Tin C (2019) The synergy between CRISPR and chemical engineering. Curr Gene Ther 19:147–171

    Article  CAS  PubMed  Google Scholar 

  23. Ortinski PI, O’Donovan BO, Dong X et al (2017) Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR/Cas9-mediated gene editing. Mol Ther Methods Clin Dev 5:153–164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Maggio I, Zittersteijn HA, Wang Q et al (2020) Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components. Gene Ther 27:209–225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ran FA, Hsu PD, Wright J et al (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8:2281–2308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tycko J, Myer VE, Hsu PD (2016) Methods for optimizing CRISPR-Cas9 genome editing specificity. Mol Cell 6:355–370

    Article  Google Scholar 

  27. Nishimasu H, Shi X, Ishiguro S et al (2018) Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361:1259–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kleinstiver BP, Sousa AA, Walton RT et al (2019) Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol 37:276–282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Cortizas EM, Zahn A, Hajjar MR et al (2013) Alternative end-joining and classical nonhomologous end-joining pathways repair different types of double-strand breaks during class-switch recombination. J Immunol 191:5751–5763

    Article  CAS  PubMed  Google Scholar 

  30. Yu KR, Natanson H, Dunbar CE (2016) Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles. Hum Gene Ther 27:729–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Yeh CD, Richardson CD, Corn JE (2019) Advances in genome editing through control of DNA repair pathways. Nat Cell Biol 21:1468–1478

    Article  CAS  PubMed  Google Scholar 

  32. Roth TL, Puig-Saus C, Yu R et al (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405–409

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hornung V, Latz E (2010) Intracellular DNA recognition. Nat Rev Immunol 10:123–130

    Article  CAS  PubMed  Google Scholar 

  34. Yoshimi K, Kunihiro Y, Kaneko T et al (2016) ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes. Nat Commun 7:10431–10431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Miura H, Quadros RM, Gurumurthy CB et al (2018) Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors. Nat Protoc 13:195–215

    Article  CAS  PubMed  Google Scholar 

  36. Bak RO, Dever DP, Porteus MH (2018) CRISPR/Cas9 genome editing in human hematopoietic stem cells. Nat Protoc 13:358–376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Khan IF, Hirata RK, Russell DW (2011) AAV-mediated gene targeting methods for human cells. Nat Protoc 6:482–501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Grieger JC, Choi VW, Samulski RJ (2006) Production and characterization of adeno-associated viral vectors. Nat Protoc 1:1412–1428

    Article  CAS  PubMed  Google Scholar 

  39. Fu Y, Folden JA, Khayter C et al (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822–826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sentmanat MF, Peters ST, Florian CP et al (2018) A survey of validation strategies for CRISPR-Cas9 editing. Sci Rep 8:888

    Article  PubMed  PubMed Central  Google Scholar 

  41. Brinkman EK, Chen T, Amendola M et al (2014) Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res 42:e168

    Article  PubMed  PubMed Central  Google Scholar 

  42. Martin F, Sanchez-Hernandez S, Gutierrez-Guerrero A et al (2016) Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: an overview. Int J Mol Sci 17(9):1507

    Article  PubMed Central  Google Scholar 

  43. Charlesworth CT, Camarena J, Cromer MK et al (2018) Priming human repopulating hematopoietic stem and progenitor cells for Cas9/sgRNA gene targeting. Mol Ther Nucleic Acids 12:89–104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Humbert O, Radtke S, Samuelson C et al (2019) Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates. Sci Transl Med 11:eaaw3768

    Article  PubMed  PubMed Central  Google Scholar 

  45. Brunetti L, Gundry MC, Kitano A et al (2018) Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9. J Vis Exp 10:57278

    Google Scholar 

  46. Tran NT, Sommermann T, Graf R et al (2019) Efficient CRISPR/Cas9-mdiated gene knockin in mouse hematopoietic stem and progenitor cells. Cell Rep 28:3510–3522 e5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Kaltenbach JP, Kaltenbach MH, Lyons WB (1958) Nigrosin as a dye for differentiating live and dead ascites cells. Exp Cell Res 15:112–117

    Article  CAS  PubMed  Google Scholar 

  48. Kerenyi MA (2014) LT-HSC methylcellulose assay. Bio Protoc 4(5). https://doi.org/10.21769/BioProtoc.1067

  49. Wognum B, Yuan N, Lai B et al (2013) Colony forming cell assays for human hematopoietic progenitor cells. Methods Mol Biol 946:267–283

    Article  CAS  PubMed  Google Scholar 

  50. Kuo CY, Long JD, Campo-Fernandez B et al (2018) Site-specific gene editing of human hematopoietic stem cells for X-linked Hyper-IgM syndrome. Cell Rep 23:2606–2616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Thomas KR, Folger KR, Capecchi MR (1986) High frequency targeting of genes to specific sites in the mammalian genome. Cell 44:419–428

    Article  CAS  PubMed  Google Scholar 

  52. Chen F, Pruett-Miller HY et al (2011) High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods 8:753–755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Davis L, Maizels N (2014) Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair. Proc Natl Acad Sci U S A 111:E924–E932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Laustsen A, Bak RO (2019) Electroporation-based CRISPR/Cas9 gene editing using Cas9 protein and chemically modified sgRNAs. Methods Mol Biol 1961:127–134

    Article  CAS  PubMed  Google Scholar 

  55. Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Cong L, Ran FA, Cox D et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Slaymaker IM, Gao L, Zetsche B et al (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351:84–88

    Article  CAS  PubMed  Google Scholar 

  59. Kleinstiver BP, Pattanayak V, Prew MS et al (2016) High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529:490–495

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Chen JS, Dagdas YS, Kleinstiver BP et al (2017) Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550:407–410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Fonfara I, Richter H, Bratovic M et al (2016) The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532:517–521

    Article  CAS  PubMed  Google Scholar 

  62. Kleinstiver BP, Tsai SQ, Prew MS et al (2016) Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol 34:869–874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Kim D, Kim J, Hur JK et al (2016) Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol 34:863–868

    Article  CAS  PubMed  Google Scholar 

  64. Safari F, Zare K, Negahdaripour M et al (2019) CRISPR Cpf1 proteins: structure, function and implications for genome editing. Cell Biosci 9:36

    Article  PubMed  PubMed Central  Google Scholar 

  65. Abudayyeh OO, Gootenberg JS, Konermann S et al (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353:aaf5573

    Article  PubMed  PubMed Central  Google Scholar 

  66. Cox DBT, Gootenberg JS, Abudayyeh OO et al (2017) RNA editing with CRISPR-Cas13. Science 358:1019–1027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Abudayyeh OO, Gootenber JS, Essletzbichler et al (2017) RNA targeting with CRISPR-Cas13. Nature 550:280–284

    Article  PubMed  PubMed Central  Google Scholar 

  68. Konermann S, Lotfy P, Brideau NJ et al (2018) Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173:665–676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Granados-Riveron JT, Aquino-Jarquin G (2018) CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 78:4107–4113

    Article  CAS  PubMed  Google Scholar 

  70. Makarova KS, Wolf YI, Alkhnbashi OS et al (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722–736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Harrington LB, Burstein D, Chen JS et al (2018) Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362:839–842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Moon SB, Kim DY, Ko J-H et al (2019) Recent advances in the CRISPR genome editing tool set. Exp Mol Med 51:130

    Article  PubMed Central  Google Scholar 

  73. Al-Shayeb B, Sachdeva R, Chen L-X et al (2020) Clades of huge phages from across Earth’s ecosystems. Nature 578:425–431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Pausch P, Al-Shayeb B, Bisom-Rapp E et al (2020) CRISPR-CasPhi from huge phages is a hypercompact genome editor. Science 369:333–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Dolan AE, Hou Z, Xiao Y et al (2019) Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using Type I CRISPR-Cas. Mol Cell 74:936–950 e5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Morisaka H, Yoshimi K, Okuzaki Y et al (2019) CRISPR-Cas3 induces broad and unidirectional genome editing in human cells. Nat Commun 10:5302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Ran FA, Hsu PD, Lin C-Y et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380–1389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Mal P, Aach J, Stranges PB et al (2013) CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31:833–838

    Article  Google Scholar 

  79. Guilinger JP, Thompson DB, Liu DR (2014) Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32:577–582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Rees HA, Liu DR (2018) Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet 19:770–788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Gaudelli NM, Komar AC, Rees HA (2017) Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551:464–471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Strecker J, Ladha A, Gardner Z et al (2019) RNA-guided DNA insertion with CRISPR-associated transposases. Science 365:48–53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Hess GT, Fresard L, Han K et al (2016) Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Nat Methods 13:1036–1042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Bae S, Park J, Kim JS (2014) Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30:1473–1475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Aach J, Mali P, Church GM (2014) CasFinder: flexible algorithm for identifying specific Cas9 targets in genomes (unpublished). bioRxiv. https://doi.org/10.1101/005074

  86. Heigwer F, Kerr FG, Boutros M (2014) E-CRISP: fast CRISPR target site identification. Nat Methods 11:122–123

    Article  CAS  PubMed  Google Scholar 

  87. Oliveros JC, Franch M, Tabas-Madrid D et al (2016) Breaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes. Nucleic Acids Res 44:W267–W271

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Haeussler M, Schonig K, Eckert H et al (2016) Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol 17:148

    Article  PubMed  PubMed Central  Google Scholar 

  89. Labun K, Montague TG, Krause M et al (2019) CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res 47:W171–W174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Sanson KR, Hanna RE, Hegde M et al (2018) Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun 9:416

    Article  Google Scholar 

  91. Stemmer M, Thumberger T, Keyer M et al (2017) Correction: CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLoS One 12:e0176619

    Article  PubMed  PubMed Central  Google Scholar 

  92. O’Brien A, Bailey TL (2014) GT-scan: identifying unique genomic targets. Bioinformatics 30:2673–2675

    Article  PubMed  PubMed Central  Google Scholar 

  93. Naito Y, Hino K, Bono H et al (2015) CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics 31:1120–1123

    Article  CAS  PubMed  Google Scholar 

  94. Xie S, Shen B, Zhang C et al (2014) sgRNAcas9: a software package for designing CRISPR sgRNA and evaluating potential off-target cleavage sites. PLoS One 9:e100448

    Article  PubMed  PubMed Central  Google Scholar 

  95. Tsai SQ, Nguyen NT, Malagon-Lopez J et al (2017) CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nat Methods 1:607–614

    Article  Google Scholar 

  96. Kim D, Bae S, Park J et al (2015) Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods 12:37–43

    Article  Google Scholar 

  97. Cameron P, Fuller CK, Donohoue PD et al (2017) Mapping the genomic landscape of CRISPR-Cas9 cleavage. Nat Methods 14:600–606

    Article  CAS  PubMed  Google Scholar 

  98. Yan WX, Mirzazadeh R, Garnerone S et al (2017) BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks. Nat Commun 8:15058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Tsai SQ, Zheng Z, Ngguyen NT et al (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187–189

    Article  CAS  PubMed  Google Scholar 

  100. Hu J, Meyers RM, Dong J et al (2016) Detecting DNA double-stranded breaks in mammalian genomes by linear amplification-mediated high-throughput genome-wide translocation sequencing. Nat Protoc 11:53–871

    Article  Google Scholar 

  101. Wienert B, Wyman SK, Richardson CD et al (2019) Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science 364:286–289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Center, Seattle, WA, USA

    Reza Shahbazi, Patricia Lipson, Karthikeya S. V. Gottimukkala, Daniel D. Lane & Jennifer E. Adair

  2. University of Washington, Seattle, WA, USA

    Jennifer E. Adair

Authors
  1. Reza Shahbazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia Lipson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karthikeya S. V. Gottimukkala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel D. Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer E. Adair
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer E. Adair .

Editor information

Editors and Affiliations

  1. Department of Microbiology & Immunology and Department of Medicine/Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN, USA

    Louis M. Pelus

  2. Moderna Therapeutics, Cambridge, MA, USA

    Jonathan Hoggatt

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Shahbazi, R., Lipson, P., Gottimukkala, K.S.V., Lane, D.D., Adair, J.E. (2023). CRISPR Gene Editing of Hematopoietic Stem and Progenitor Cells. In: Pelus, L.M., Hoggatt, J. (eds) Hematopoietic Stem Cells. Methods in Molecular Biology, vol 2567. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2679-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2679-5_4

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2678-8

  • Online ISBN: 978-1-0716-2679-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation